The IASLC 2023 Hot Topic Meeting: Small Cell Lung Cancer is a biannual international meeting held at the Memorial Sloan Kettering Cancer Center and is focused on preclinical and clinical advances in small cell lung cancer research. This includes basic research on oncogenesis and biology of disease, preclinical therapeutic research, and highlights of ongoing clinical translation. 

A primary goal of the meeting is to bring together leading researchers focused on this tumor type to provide a broad update of progress in the field, to promote collaboration, and to prompt generation of new ideas.

Live Activity Dates: April 5 - 7, 2023

This conference is designed to meet the educational needs of researchers and healthcare professionals who diagnose and treat patients with lung cancer and other thoracic malignancies, including medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists, advanced practice nurses, physician assistants and nurses.

• Apply evidence-based recommendations and clinical practice guidelines to diagnose and treat patients with smacll cell lung cancer. 
• Describe scientific advances in small cell lung cancer. 
• Synthesize research from clinical trials and translational studies to deepen knowledge about small cell lung cancer.

Program Co-Chairs: 

• Charles Rudin, MD, PhD, Memorial Sloan Kettering Cancer Center
• Kate Sutherland PhD, University of Melbourne
• Álvaro Quintanal-Villalonga, PhD, Memorial Sloan Kettering Cancer Center 
• Kathryn Simpson, PhD, The University of Manchester
• David MacPherson, PhD., Fred Hutchinson Cancer Research Center

The information presented is that of the contributing faculty and does not necessarily represent the views of the International Association for the Study of Lung Cancer and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse effects.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

If you need assistance with this activity, please email: education@iaslc.org.